Efficacy News and Research

RSS

The effect of SGLT2 inhibitors in patients with heart failure and type 2 diabetes

Researchers assessed the impact of SGLT2 inhibitors on type 2 diabetes and heart failure patients in real-world clinical settings.

21 Jun 2023

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Researchers evaluated the effectiveness of diabetic diets containing D-allulose among type 2 diabetes patients.

21 Jun 2023

3D-printed vaginal ovules offer promising treatment for endometriosis

3D-printed vaginal ovules offer controlled release and targeted treatment, showing promise for conditions like endometriosis.

20 Jun 2023

UTHSC researchers receive major national award to find new treatments for breast cancer metastasis

UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award.

20 Jun 2023

Targeting Phage Therapy 2023 showcased the progress and possibilities of phage therapy in future

The 6th World Congress on Targeting Phage Therapy 2023 that was held on June 1-2 in Paris, and gathered more than 150 attendees from 30+ different countries. Targeting Phage Therapy 2023 included more than 71 presentations between major talks, short orals, and posters.

20 Jun 2023

Challenges associated with return to school after traumatic brain injury

Each year nearly 900,000 US children up to 19 years of age sustain a traumatic brain injury (TBI) requiring hospitalization or emergency treatment.

20 Jun 2023

Radiation combined with cancer-targeting virus therapy more effective in fighting brain tumors

Combining a cancer-targeting virus with radiation to treat brain cancer in mice was more effective than either therapy on its own according to University of Alberta research, providing hope for new treatments that combine immunotherapy with traditional surgery, chemotherapy or radiation.

20 Jun 2023

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.

20 Jun 2023

Exercise is a viable intervention for improving depression and anxiety in young individuals, study finds

Study identifies the best type of exercise for preventing and treating depression in young individuals.

20 Jun 2023

Battle against RSV: Computational design paves way for new polyvalent vaccine

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes computational methods and immunoinformatics tools to predict potential vaccine candidates and their interactions with Toll-like receptors (TLRs).

19 Jun 2023

Wearable tech reveals: Social constructs and physical activity shape global sleep patterns

Researchers analyze sleep data from wearable devices to assess sleep patterns. Societal factors influence sleep quality and quantity, with exercise playing a positive role. Understanding social norms can help enhance the benefits of sleep on health and well-being.

19 Jun 2023

Unlocking HIV cure: Study highlights allogeneic immunity as key mechanism in eradicating latent virus reservoirs

Allogeneic stem cell transplantation with CCR5Δ32/Δ32 donors shows potential for HIV cure. Alloimmunity and CCR5 deficiency play significant roles in viral reservoir clearance.

19 Jun 2023

AI chatbots in dermatology: Promising, but proceed with caution, says new study

Study finds AI chatbots in dermatology show promise in answering patient questions and simplifying medical jargon, but limitations in accuracy and knowledge highlight the need for cautious integration into clinical practice.

18 Jun 2023

Smart drugs fall short as cognitive function enhancers

A recent Science Advances study investigated the effectiveness of three popular smart drugs, namely, modafinil (MOD), methylphenidate (MPH), and dextroamphetamine (DEX), against the difficulty of real-life daily tasks, i.e., the 0-1 knapsack optimization problem (“knapsack task”). A knapsack task is basically a combinatorial optimization task, the class of NP-time challenging problems.

18 Jun 2023

Intravenous treatment with MK-3402 can be an effective strategy in fighting antimicrobial resistance

New research by investigators in Ghent, Belgium shows that intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be an effective strategy in fighting antimicrobial resistance. The findings are presented at ASM Microbe 2023, the annual meeting of the American Society for Microbiology.

18 Jun 2023

Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer

Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients with KRAS G12C-mutated non-small cell lung cancer.

16 Jun 2023

Rice U. chemist wins NSF award to investigate how heterogeneity affects chemical and biological processes

Rice University chemist Anatoly Kolomeisky has won an award from the National Science Foundation to investigate how heterogeneity affects chemical and biological processes.

16 Jun 2023

Study concludes a single intramuscular injection of adintrevimab provides prophylactic efficacy against COVID-19 without safety concerns

Researchers evaluated the prophylactic immune protection conferred by a single intramuscular injection of adintrevimab (ADG20) against symptomatic COVID-19.

16 Jun 2023

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.

16 Jun 2023

COVID-19 susceptibility mechanism discovered using a newly created tool

Researchers have discovered a mechanism for COVID-19 susceptibility using a newly created tool. The tool, GASPACHO, captures dynamic changes in gene expression along the innate immune response, allowing researchers to identify genes and molecular pathways associated with disease risk that have previously been too complex to detect or interpret.

15 Jun 2023

Efficacy News and Research

The effect of SGLT2 inhibitors in patients with heart failure and type 2 diabetes

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

3D-printed vaginal ovules offer promising treatment for endometriosis

UTHSC researchers receive major national award to find new treatments for breast cancer metastasis

Targeting Phage Therapy 2023 showcased the progress and possibilities of phage therapy in future

Challenges associated with return to school after traumatic brain injury

Radiation combined with cancer-targeting virus therapy more effective in fighting brain tumors

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Exercise is a viable intervention for improving depression and anxiety in young individuals, study finds

Battle against RSV: Computational design paves way for new polyvalent vaccine

Wearable tech reveals: Social constructs and physical activity shape global sleep patterns

Unlocking HIV cure: Study highlights allogeneic immunity as key mechanism in eradicating latent virus reservoirs

AI chatbots in dermatology: Promising, but proceed with caution, says new study

Smart drugs fall short as cognitive function enhancers

Intravenous treatment with MK-3402 can be an effective strategy in fighting antimicrobial resistance

Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer

Rice U. chemist wins NSF award to investigate how heterogeneity affects chemical and biological processes

Study concludes a single intramuscular injection of adintrevimab provides prophylactic efficacy against COVID-19 without safety concerns

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

COVID-19 susceptibility mechanism discovered using a newly created tool

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News